Evidence map›Paper›PMID 37704782›Full record

ArticleNature methods2023

Extending support for mouse data in the Molecular Signatures Database (MSigDB).

Anthony S Castanza, Jill M Recla, David Eby, Helga Thorvaldsdóttir, Carol J Bult, Jill P Mesirov

Abstract readLetter
In one paragraph

Article in Nature methods, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 324 papers.

0numbers the graph read from it
0cells of the map it votes in
324citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

324 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Chemically modified CRISPR enzymes for multi-organ genome editingbioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Article
  17. Rbp-Jκ controls NK cell late maturation and migration via chromatin landscape remodeling.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  18. Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  19. Early-life colonization withScience (New York, N.Y.) · 2026
    Article
  20. Article

264 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anthony S CastanzaDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0001-9795-0720
Jill M ReclaThe Jackson Laboratory for Mammalian Genomics, Bar Harbor, ME, USA.
David EbyDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0001-5771-0300
Helga ThorvaldsdóttirBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Carol J BultThe Jackson Laboratory for Mammalian Genomics, Bar Harbor, ME, USA.ORCID 0000-0001-9433-210X
Jill P MesirovDepartment of Medicine, University of California San Diego, La Jolla, CA, USA. jmesirov@health.ucsd.edu.ORCID 0000-0002-9755-2818

Funding

Supporting and evolving Gene Set Enrichment Analysis and the Molecular Signatures Database for cancer researchU24CA220341 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MESIROV, JILL P., TAMAYO, PABLO · 2018 to 2022
$3.4M
NCI NIH HHS U24 CA220341
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Databases, GeneticGene Expression ProfilingAnimalsDatabases, ChemicalMice

Identifiers

PMID37704782
PMCPMC11397807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.